CA
PRCT icon

CoreCap Advisors’s Procept Biorobotics PRCT Stock Holding History

CoreCap Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158 Hold
7
– – ﹤0.01% 3031
2026
Q1 		$175 Hold
7
– – ﹤0.01% 2775
2025
Q4 		$220 Buy
+7
New +$232 ﹤0.01% 2804
2025
Q1 		– Sell
-55
Closed -$4.43K – 3268
2024
Q4 		$4.43K Buy
+55
New +$4.7K ﹤0.01% 2002

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CoreCap Advisors's PRCT Position: Q2 2026 in Review

CoreCap Advisors held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 7 shares worth $158. The position accounts for ﹤0.01% of the portfolio, ranked #3031.

CoreCap Advisors first reported a position in PRCT in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.43K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • CoreCap Advisors held 7 shares of Procept Biorobotics worth $158 as of Q2 2026.
  • CoreCap Advisors left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #3031 holding.
  • CoreCap Advisors first reported a position in Procept Biorobotics in Q4 2024 and has held it in 4 quarters since.
  • CoreCap Advisors's Procept Biorobotics position peaked at $4.43K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.